Sunday, July 22, 2018
Company News: Page (1) of 1 - 07/11/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Parsa Mohebi Now Announces Innovative Device to Assist in Placing Hair Follicles During a Hair Transplant
Dr. Parsa Mohebi, a leading hair restoration surgeon in Los Angeles, announces the Mohebi Implanter to aid in making the placement of hair follicular unit grafts easier.
(July 11, 2018)

LOS ANGELES, Jul. 11, 2018 /PRNewswire-PRWeb/ -- Dr. Parsa Mohebi, founder of Los Angeles-based Parsa Mohebi Hair Restoration, announces the invention and implementation of the Mohebi Implanter. According to Dr. Mohebi, "This innovative device makes the placement of hair follicular grafts easier as well as safer during the hair transplant process."

When asked how the implanter, named after Dr. Mohebi, works to reduce the trauma to the grafts, he said "the implanter minimizes the manipulative forces that have the possibility of injuring the bulb of the follicles. In addition, the device improves the overall efficiency and execution of a hair transplant by allowing each individual operator the chance to load and place their own grafts during the procedure."

The Mohebi implanter has a blunt tip that aids in the placement of hair follicular grafts into the sites on the scalp that are premade by medical technicians. Dr. Mohebi said he is especially happy with the short learning curve involved in the use of the implanter. He added this means any new operator can quickly learn the art of efficiently placing grafts in as short as a few weeks. Dr. Mohebi stated, "my new implanter is an ideal tool for the placement of grafts by several technicians at the same time during the surgery. In addition, it can be used effectively during simultaneous extraction and placement of FUE procedures since the Mohebi implanter allows for single handed graft placement by multiple technicians working at the same time."

When asked why he decided to create the Mohebi Implanter, Dr. Mohebi said, "I am always looking for ways to increase the ease of surgery for our patients. The Mohebi implanter reduces the chances of the follicles being injured but it doesn't reduce the natural looking results that our patients have come to expect. The implanter allows for multiple technicians to work at the same time which means the process is more efficient. The comfort of our patients is always our main goal and the Mohebi implanter allows us to make the surgery safer and more efficient for patients of all ages."

About Dr. Parsa Mohebi:
As the first chairman of the FUE Research Committee of the International Society of Hair Restoration and creator of several methods and techniques in modern hair restoration, Dr. Mohebi, along with his staff, provides his patients with the most advanced hair restoration techniques currently available. Dr. Mohebi has been in the forefront of new research and developing the latest technology to advance the field of hair restoration. Dr. Mohebi is a Diplomat of the American Board of Hair Restoration and a fellow of the International Society of Hair Restoration.


SOURCE Parsa Mohebi Hair Restoration

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Sexual,Surgery,Surgery,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

  • BeiGene Announces Plan to Pursue Accelerated Approval in the U.S. of BTK Inhibitor Zanubrutinib in Waldenström Macroglobulinemia (WM)
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines